| Steven Barry Machtinger, MD | |
|
725 Welch Rd, Palo Alto, CA 94304-1601 | |
| (650) 497-8000 | |
| Not Available |
| Full Name | Steven Barry Machtinger |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 47 Years |
| Location | 725 Welch Rd, Palo Alto, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093719437 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Medical Center | Burlingame, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steven Machtinger Md And Associates Inc | 1850543372 | 2 |
News Archive
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
A new study has found that more and more Americans are being diagnosed with opioid addiction and the numbers that receive treatment are still very few. This finding is consistent with earlier findings from Blue Cross Blue Shield when analyzing member data.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.
› Verified 3 days ago
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
A new study has found that more and more Americans are being diagnosed with opioid addiction and the numbers that receive treatment are still very few. This finding is consistent with earlier findings from Blue Cross Blue Shield when analyzing member data.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.
› Verified 3 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
A new study has found that more and more Americans are being diagnosed with opioid addiction and the numbers that receive treatment are still very few. This finding is consistent with earlier findings from Blue Cross Blue Shield when analyzing member data.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.
› Verified 3 days ago
| Entity Name | Steven Machtinger Md & Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427288133 PECOS PAC ID: 1850543372 Enrollment ID: O20121210000073 |
News Archive
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
A new study has found that more and more Americans are being diagnosed with opioid addiction and the numbers that receive treatment are still very few. This finding is consistent with earlier findings from Blue Cross Blue Shield when analyzing member data.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven Barry Machtinger, MD 725 Welch Rd, Palo Alto, CA 94304-1601 Ph: (650) 497-8000 | Steven Barry Machtinger, MD 725 Welch Rd, Palo Alto, CA 94304-1601 Ph: (650) 497-8000 |
News Archive
There is a high rate of prescription pain reliever abuse in Europe, largely accounted by opioids, according to the first comparative study of prescription drug abuse in the European Union, which was conducted by researchers at RTI International and published in BMC Psychiatry.
A new study has found that more and more Americans are being diagnosed with opioid addiction and the numbers that receive treatment are still very few. This finding is consistent with earlier findings from Blue Cross Blue Shield when analyzing member data.
Delcath Systems, Inc. announced today that it has executed a multi-year supply agreement with Synerx Pharma, LLC and Bioniche Teoranta, an affiliate of Mylan, Inc., for the supply of Delcath's branded melphalan hydrochloride for injection ("melphalan"). Melphalan is the chemotherapeutic drug used with Delcath's Chemosaturation system in its Phase III clinical study for the treatment of patients with hepatic metastases from ocular or cutaneous melanoma.
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.
› Verified 3 days ago
Kevin Wei-han Chi, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Jean Chia, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 730 Welch Rd, Palo Alto, CA 94304 Phone: 650-721-6073 | |
Dr. Myrna Maria Mungal, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Shalini Mittal, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Erin E Holsinger, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Dr. Jerome Linus Murphy, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 | |
Peter Andrew Meaney, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 725 Welch Rd, Palo Alto, CA 94304 Phone: 650-497-8000 |